PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
The University of Texas MD Anderson Cancer Center · Ionis Pharmaceuticals (United States)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,865
total citations
- FWCI
- 43.37
- Percentile
- 100%
- References
- 73
Citations per year
Authors
13- YNYoichi Nagata
The University of Texas MD Anderson Cancer Center
- KLKeng‐Hsueh Lan
The University of Texas MD Anderson Cancer Center
- XZXiaoyan Zhou
The University of Texas MD Anderson Cancer Center
- MTMing Tan
The University of Texas MD Anderson Cancer Center
- FJFrancisco J. Esteva
The University of Texas MD Anderson Cancer Center
Topics & keywords
Topics
Keywords
- Trastuzumab
- PTEN
- Cancer research
- PI3K/AKT/mTOR pathway
- Breast cancer
- Medicine
- Cancer
- Biology
UN Sustainable Development Goals
- No poverty
No related works found for this paper.